two sigma logo two sigma logo
Subscribe
Data Science, Engineering, Partnerships, Social Impact

Building an Interactive Dashboard to Support Leaders Managing COVID-19 in Africa

Science lab where a gloved hand tests COVID 19 samples.
Click if you learned something new
Data Clinic partnered with the COVID-19 in Africa Data Science Initiative to increase access to their context-specific insights.

Over the past year, we have seen countless data visualizations, dashboards, and charts all detailing the spread of COVID-19 around the world. While some of these dashboards are excellent sources of information, few of them take into account regional variations in the factors associated with transmission. The COVID-19 in Africa Data Science Initiative is a collaboration between researchers at Boston University and other academic institutions around the world that was constituted to model and map the trajectory of COVID-19 on the African continent as well as develop tools to aid policy makers in real-time decision-making leading to efficient resource and therapeutic allocation. Data Clinic collaborated with the COVID-19 in Africa Data Science team to develop an open source interactive multilingual dashboard that facilitates access to their insights and supports decision-makers across the continent.

The dashboard, written using a React-based frontend and a NestJS API, displays infection, recovery, and death statistics for each African country along with COVID-19 infection forecasts based on the model produced by the COVID-19 in Africa Data Science Initiative.

The dashboard is still in development, with more features to come. Stay tuned for updates, and in the meantime — please share your feedback or open a ticket on GitHub.

To learn more about the methodologies and decisions behind the model and the dashboard, please visit their respective GitHub repositories:

Click if you learned something new
Read more from Data Clinic

Tags

covid-19 / data clinic / data science / open data / open source / tech for good

This article is not an endorsement by Two Sigma of the papers discussed, their viewpoints or the companies discussed. The views expressed above reflect those of the authors and are not necessarily the views of Two Sigma Investments, LP or any of its affiliates (collectively, “Two Sigma”). The information presented above is only for informational and educational purposes and is not an offer to sell or the solicitation of an offer to buy any securities or other instruments. Additionally, the above information is not intended to provide, and should not be relied upon for investment, accounting, legal or tax advice. Two Sigma makes no representations, express or implied, regarding the accuracy or completeness of this information, and the reader accepts all risks in relying on the above information for any purpose whatsoever. Click here for other important disclaimers and disclosures.